Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - The Serrated Pathway and Colorectal Cancer Screening, 3/5/2021 8:00:00 AM - 3/5/2024 9:00:00 AM, Dr. Anderson discusses the pathways for the development of colorectal cancer (CRC) with a focus on serrated adenomas. There is evolving evidence regarding the potential for dysplasia with the serrated subtype of hyperplastic polyps, once thought to be benign. Challenges in diagnosis and management include interpretation of pathologic specimens, detection, resection and follow up. Ongoing research seeks to identify and disseminate effective surveillance strategies for serrated polyp management.
Presenter
Joseph C. Anderson, MD
Associate Professor of Medicine
Geisel School of Medicine at Dartmouth
Staff Gastroenterologist, VA Medical Center
Chair, Research and Development Committee, VA Medical Center
Adjunct Associate Professor, University of Connecticut Health Center
About our Presenter
Dr. Joseph Anderson graduated from the University of Pennsylvania with a degree in engineering, and received his MD degree from the Mount Sinai Medical School. He completed his residency and fellowship in Gastroenterology at Stony Brook University where he joined the tenured staff. He has been on faculty at the University of Connecticut since 2007 where he is an associate professor and actively collaborates with UConn faculty and lectures students and trainees there.
Learning Outcome(s)
Participants will be able to discuss the epidemiology and management of serrated polyps and the molecular and clinical factors that are associated with the development of CRC in the serrated pathway.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Presenter
Joseph C. Anderson, MD
Associate Professor of Medicine
Geisel School of Medicine at Dartmouth
Staff Gastroenterologist, VA Medical Center
Chair, Research and Development Committee, VA Medical Center
Adjunct Associate Professor, University of Connecticut Health Center
About our Presenter
Dr. Joseph Anderson graduated from the University of Pennsylvania with a degree in engineering, and received his MD degree from the Mount Sinai Medical School. He completed his residency and fellowship in Gastroenterology at Stony Brook University where he joined the tenured staff. He has been on faculty at the University of Connecticut since 2007 where he is an associate professor and actively collaborates with UConn faculty and lectures students and trainees there.
Learning Outcome(s)
Participants will be able to discuss the epidemiology and management of serrated polyps and the molecular and clinical factors that are associated with the development of CRC in the serrated pathway.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.